Menopause Specialist in Miami: What Midlife Care Should Actually Measure
A menopause specialist in Miami is a clinician with dedicated training in the menopause transition — most often a board-certified internist, gynecologist, or endocrinologist who has completed additional certification through the Menopause Society (formerly the North American Menopause Society). The distinction that matters clinically is not the specialty label but the scope of the evaluation: whether the visit treats hot flashes alone, or whether it also measures the cardiovascular and skeletal changes that accelerate during the same years. At PURE Executive Health & Wellness in Coral Gables, midlife care is built into a comprehensive executive health assessment for exactly that reason.
This article is intended for women in Miami seeking comprehensive menopause care and for anyone interested in understanding what distinguishes high-quality midlife health assessment from standard symptom management.
Most menopause care in South Florida is organized around symptom relief. That is a legitimate and often urgent goal. But it is an incomplete one, and the incompleteness has a cost that does not show up for a decade or more.
What Is a Menopause Specialist, and What Specialist Treats Menopause?
There is no ACGME residency in menopause. A physician becomes a menopause specialist by adding focused training and, in most cases, by earning the Menopause Society’s practitioner credential — awarded to clinicians who pass a competency examination in midlife women’s health and the end of a woman’s reproductive years.
Those clinicians come from several backgrounds. Gynecologists are the most common. Internists are the second most common, and for women whose primary midlife concerns are cardiometabolic rather than gynecologic, an internist may be the more natural fit, because the same physician who manages the menopause transition also manages blood pressure, lipids, glucose, and bone health as menopause marks the end of the reproductive years and ovarian hormone production changes.
At PURE, Sudha Lolayekar, MD is board-certified in internal medicine and a certified menopause practitioner. She spent eighteen years as an Assistant Professor of Clinical Medicine at the University of Miami before joining the practice. The combination is deliberate: menopause managed by an internist keeps the transition inside a broader risk picture rather than isolating it.
Menopause and Cardiovascular Disease: The Window Most Practices Skip
Cardiovascular disease is the leading cause of death in women, and women typically develop coronary heart disease several years later than men — a pattern that led researchers to ask whether the menopause transition itself contributes to that risk.
According to research published in Circulation, the American Heart Association’s 2020 scientific statement on the menopause transition concluded that longitudinal studies following women through menopause have documented distinct patterns of sex hormone change alongside adverse alterations in body composition, lipids and lipoproteins, and measures of vascular health. The statement describes the transition as “a time of accelerating CVD risk” and emphasizes midlife as a critical window for implementing early intervention strategies, noting that postmenopausal women face increased risk as hormonal and metabolic changes affect body composition (El Khoudary et al., Circulation, 2020; DOI: 10.1161/CIR.0000000000000912).
This is the practical consequence: a midlife visit that measures only symptoms, and does not assess hormonal changes, lipids, lipoprotein particle burden, blood pressure trajectory, visceral adiposity, glucose handling, weight gain, and mental well-being, is skipping the window the AHA identified. Symptom control and risk assessment are not the same clinical task, and doing the first does not accomplish the second.
Bone Loss Begins Before the Final Period, Not After It
The timing of skeletal change is widely misunderstood, including by patients who have been told to start thinking about bone density “after menopause,” even though perimenopause often begins in the mid to late 40s and hormonal changes can drive bone loss before the transition is complete.
According to research published in the Journal of Bone and Mineral Research, the Study of Women’s Health Across the Nation followed 862 women through their final menstrual period and found that bone mineral density loss began one year before the final period, with menopause defined after 12 consecutive months without a period, and decelerated two years after it. Over the ten-year observation window, cumulative lumbar spine loss was 10.6% — and 7.38 percentage points of that, roughly seven-tenths of the total decade of loss, occurred inside the three-year “transmenopause” window alone. Femoral neck loss followed the same pattern: 9.1% cumulative, 5.8% during transmenopause (Greendale et al., J Bone Miner Res, 2012; DOI: 10.1002/jbmr.534).
A woman who waits until she is postmenopausal to obtain her first DEXA scan has, on average, already passed through the interval in which roughly 70% of her decade’s lumbar spine bone loss occurred, and the average age of menopause in the U.S. is 51 years. That is an argument for baseline measurement during perimenopause, not after it.
How Long Symptoms Actually Last
Practice websites across Miami commonly state that menopause “lasts about four to five years.” The published cohort data do not support that figure for women with frequent symptoms.
According to research published in JAMA Internal Medicine, the SWAN cohort followed 3,302 women across seven U.S. sites from 1996 through 2013, analyzing 1,449 women who reported frequent vasomotor symptoms. The median total duration of frequent hot flashes and night sweats was 7.4 years, and symptoms persisted a median of 4.5 years after the final menstrual period. Women who first reported frequent symptoms while still premenopausal or in early perimenopause had a median total duration exceeding 11.8 years. African American women in the cohort reported the longest median duration at 10.1 years (Avis et al., JAMA Intern Med, 2015; DOI: 10.1001/jamainternmed.2014.8063).
The authors’ conclusion was directed at clinicians: counsel women that the symptoms of menopause can include hot flashes and mood changes, and that frequent symptoms could last more than seven years. For a woman running a company, a fund, or a household in Coral Gables or Brickell, the difference between planning for eighteen months and planning for seven years is not academic.
Hormone Therapy and the Timing Question
Hormone therapy helps relieve hot flashes during menopause and is the most effective available treatment for vasomotor symptoms, though menopause is a natural part of aging even when treatment is helpful. Whether it also affects cardiovascular outcomes is genuinely contested, and any practice that presents it as settled is overselling.
The “timing hypothesis” proposes that cardiovascular effects depend on when therapy begins relative to menopause. According to research published in the Journal of Women’s Health, subgroup analyses of the Women’s Health Initiative alongside the KEEPS and ELITE randomized trials indicate that the risk of adverse cardiovascular events from hormone therapy is low for women under 60 or within ten years of menopause. The same review is explicit that current data do not support using hormone therapy for primary prevention of cardiovascular disease — only that it can be used safely to treat symptoms in appropriately selected women close to menopause (Mehta, Chester & Kling, J Womens Health, 2018; DOI: 10.1089/jwh.2018.7201).
That position is not universally held. According to research published in the American Journal of Epidemiology, a detailed review of WHI data argued that findings for women initiating therapy soon after menopause showed similar null or adverse effects on coronary heart disease risk and similar adverse effects on stroke and venous thrombosis risk compared with later initiation — concluding that WHI data do not support the timing hypothesis (Banks & Canfell, Am J Epidemiol, 2009; DOI: 10.1093/aje/kwp113).
Both citations belong in an honest discussion. The clinical implication is that hormone therapy is a decision requiring individual risk assessment — personal and family history of breast cancer, thromboembolism, stroke, and cardiovascular disease — rather than a default. Specialists prescribe FDA-approved hormone replacement therapy for symptom management. PURE’s approach to hormone replacement therapy is built on that individualized assessment to balance hormone levels and increase estrogen levels when appropriate. Treatment may use estrogen, and progesterone is added when needed to protect the uterine lining. Vaginal estrogen can decrease vaginal dryness in menopausal women. Low-dose antidepressants can reduce hot flashes and help with mood swings in some women when hormone therapy is not appropriate. These medications may also provide relief for other symptoms, including changes affecting the skin.
Choosing a Female Concierge Doctor in Miami for Midlife Care
Women searching for a female concierge doctor in Miami are usually solving for two things at once: a physician who will take midlife symptoms seriously and explain menopause as a natural process in a woman’s life, and enough appointment time to work through a decision that has real trade-offs. They should also receive guidance on lifestyle changes to manage menopause symptoms, since this stage of life can affect daily life and leave many women to suffer through symptoms that disrupt sleep.
Standard practice economics work against both. Lifestyle changes can alleviate menopause symptoms effectively, but topics like regular exercise and when to schedule follow-up care need enough visit time to discuss properly, especially because this stage can disrupt sleep and affect quality of life more broadly. A fifteen-minute visit cannot accommodate a considered conversation about hormone therapy risk, a review of a lipid panel, and a discussion of bone density. A membership practice changes the constraint. At PURE, appointment length is set by the complexity of the problem, and the physician who orders a test is the physician who interprets it and manages what it finds.
How PURE Approaches Midlife Health in Coral Gables
Comprehensive Symptom and Risk Assessment
PURE Executive Health & Wellness is a concierge practice in Coral Gables serving executives and their families across Brickell, Coconut Grove, Key Biscayne, Fisher Island, Pinecrest, South Miami, and Miami Beach. Midlife evaluation is delivered inside PURE’s executive health assessment rather than as a separate symptom appointment.
In practice that means symptom assessment and risk assessment happen in the same evaluation: a detailed symptom and menstrual history, including changes in menstrual periods and noting that some women experience menopause symptoms before age 40 when early loss of ovarian function can occur as the ovaries produce less estrogen; review of menopausal symptoms and other common symptoms women experience, including mood changes, sexual health, urinary symptoms, and brain fog, as these changes occur through the transition; cardiometabolic laboratory work including advanced lipid measures, blood pressure and body composition, bone density imaging where indicated by risk, and an individualized discussion of hormonal and non-hormonal treatment options. Symptom management includes relief for hot flashes, sleep disturbances, and mood changes.
Personalized Diagnostic Sequencing
Jennifer Miranda, MD, PURE’s founder and medical director, sequences diagnostics against individual history rather than ordering a fixed panel.
This article is educational and is not medical advice or a diagnosis. Individual results vary, and decisions about hormone therapy or any other treatment should be made with a qualified physician who knows your history. To discuss what a midlife assessment would include for you, contact PURE at 786-227-6811.
Frequently Asked Questions
What is a menopause specialist called?
A clinician with formal credentialing in midlife women’s health is commonly called a certified menopause practitioner, a credential awarded by the Menopause Society after a competency examination. The Menopause Society, which maintains a searchable database of certified practitioners, awards the certified menopause practitioner credential to clinicians who pass a competency examination in midlife women’s health.
What specialist treats menopause?
Gynecologists, internists, and endocrinologists all treat menopause. An internist with menopause certification is often appropriate when cardiometabolic and bone health are primary concerns, because the transition is managed alongside blood pressure, lipids, glucose, and bone density rather than separately from them.
How long do menopause symptoms last?
Longer than commonly stated. In the SWAN cohort published in JAMA Internal Medicine, the median total duration of frequent hot flashes and night sweats was 7.4 years, with a median of 4.5 years of persistence after the final menstrual period. Women whose symptoms began in premenopause or early perimenopause had a median duration exceeding 11.8 years.
When should I have a bone density scan relative to menopause?
Discuss baseline testing during perimenopause rather than waiting until after the final period. SWAN data published in the Journal of Bone and Mineral Research show bone loss begins about one year before the final menstrual period, and 7.38 of the 10.6 percentage points of ten-year lumbar spine loss occur within the surrounding three-year window. Timing of testing should be individualized with your physician, because menopause occurs at different times by age. The average age of menopause onset is 51 years.
Does menopause increase cardiovascular risk?
The American Heart Association’s 2020 scientific statement in Circulation describes the menopause transition as a period of accelerating cardiovascular disease risk, accompanied by adverse changes in lipids, body composition, and vascular measures, and identifies midlife as a critical window for early prevention.
Is hormone therapy safe?
It depends on individual risk and timing, and the evidence is not unanimous. Reviews in the Journal of Women’s Health report low cardiovascular risk for symptomatic women under 60 or within ten years of menopause, while stating hormone therapy is not indicated for primary cardiovascular prevention; when clinically indicated, osteoporosis medication can help slow bone loss during menopause. Other analyses of Women’s Health Initiative data dispute the timing hypothesis entirely. This is a decision for an individualized risk assessment with a physician, not a general recommendation.
Do you offer menopause care in Coral Gables and Miami Beach?
Yes. PURE Executive Health & Wellness is located in Coral Gables and serves members across Brickell, Coconut Grove, Key Biscayne, Fisher Island, Indian Creek, Pinecrest, South Miami, and Miami Beach.